✦ LIBER ✦

Response to Alendronate in Osteoporosis after Previous Treatment with Etidronate

✍ Scribed by A. Fairney; P. Kyd; E. Thomas; J. Wilson

Publisher: Springer-Verlag
Year: 2000
Tongue: English
Weight: 97 KB
Volume: 11
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s001980070084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone Turnover and the Response to Alendr

Bone Turnover and the Response to Alendronate Treatment in Postmenopausal Osteoporosis

✍ S. Gonnelli; C. Cepollaro; C. Pondrelli; S. Martini; A. Montagnani; R. Monaco; C 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 299 KB

A Comparison of Continuous Alendronate,

A Comparison of Continuous Alendronate, Cyclical Alendronate and Cyclical Etidronate with Calcitriol in the Treatment of Postmenopausal Vertebral Osteoporosis: A Randomized Controlled Trial

✍ O. Sahota; I. Fowler; P. J. Blackwell; N. Lawson; S. A. Cawte; P. San; T. Masud; 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 164 KB

Predicting Subsequent Bone Density Respo

Predicting Subsequent Bone Density Response to Intermittent Cyclical Therapy with Etidronate from Initial Density Response in Patients with Osteoporosis

✍ R. G. Crilly; R. J. Sebaldt; A. B. Hodsman; J. D. Adachi; J. P. Brown; C. H. Gol 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 117 KB

Enhanced response to basiliximab in a pa

Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression

✍ Jessica A. Berman; Kashyap Patel; Jaime Caro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

Dopaminergic responsiveness to apomorphi

Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease

✍ J. Vaamonde; M. R. Luquin; Dr. J. A. Obeso 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract The aim of this study was to assess whether or not continuous infusion of lisuride in combination with intermittent levodopa‐carbidopa administration was associated with tolerance. Intravenous apomorphine was given to four patients before initiation of chronic treatment with subcutaneou

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of